Amgicin 200 Gemcitabine Injection IP 200 Mg
Amgicin 200 Gemcitabine Injection IP 200 Mg

Amgicin 200 Gemcitabine Injection IP 200 Mg

MOQ : 10 Pieces

Amgicin 200 Gemcitabine Injection IP 200 Mg Specification

  • Salt Composition
  • Gemcitabine 200 mg
  • Indication
  • Used in the treatment of various cancers such as pancreatic cancer, breast cancer, ovarian cancer, and non-small cell lung cancer
  • Dosage Form
  • Injection
  • Feature
  • Sterile, single-use vial, for hospital/clinical use only
  • Ingredients
  • Gemcitabine Hydrochloride
  • Application
  • Intravenous use in oncology
  • Physical Color/Texture
  • Clear, colorless to light straw-colored solution
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life
  • 24 months
  • Strength
  • 200 mg per vial
  • Marketed In
  • International markets (Canada, EU, UK, USA, Australia)
  • Prescription Required
  • Yes
  • Adverse Effects
  • Myelosuppression, nausea, vomiting, rash, fever
  • Administration Route
  • Intravenous infusion after dilution
  • Formulation
  • Lyophilized powder for reconstitution
  • Contraindications
  • Known hypersensitivity to gemcitabine
  • ATC Code
  • L01BC05
  • Packaging Size
  • One vial per box
  • Precautions
  • Use with caution in patients with renal or hepatic impairment
  • Compatibility
  • Mix only with recommended diluents (as per manufacturer)
 
 

Amgicin 200 Gemcitabine Injection IP 200 Mg About



Amgicin 200 Gemcitabine Injection IP 200 Mg is a highlighted, masterful solution in oncology care, designed with sublime precision for intravenous infusion. Customizable to patient needs, each sterile, single-use vial contains 200 mg lyophilized Gemcitabine, offering ravishing results in the treatment of pancreatic, breast, ovarian, and non-small cell lung cancers. Marketed internationally, Amgicin 200 is crafted to supreme standards, providing a special rate on quality therapy. With careful compatibility instructions and a premium shelf life, it embodies sophisticated excellence in cancer management.

Comprehensive Oncology Applications

Amgicin 200 Gemcitabine Injection IP 200 Mg is specifically formulated for use in hospital and clinical oncology settings. The solution is designed for intravenous application, targeting a broad area of malignant conditions such as pancreatic, breast, ovarian, and non-small cell lung cancers. Its clear, colorless to light straw-colored composition ensures precise administration, making it ideal for professional medical environments where accuracy is paramount in cancer treatment.


Supply, Packaging, and Delivery Details

Amgicin 200 Gemcitabine Injection IP 200 Mg is charged and handed over in secure, single-use vials, meticulously packaged in individual boxes for optimal protection. The product is supplied with a robust ability to meet substantial hospital and clinical demands internationally. FOB Port services are efficiently organized, ensuring prompt delivery and smooth handling right from the point of origin to medical facilities worldwide.


FAQ's of Amgicin 200 Gemcitabine Injection IP 200 Mg:


Q: How should Amgicin 200 Gemcitabine Injection be administered for optimal results?

A: Amgicin 200 is administered as an intravenous infusion after proper dilution with the recommended diluent. The procedure should be performed by trained healthcare professionals in a hospital or clinical setting.

Q: What cancers is Amgicin 200 primarily indicated to treat?

A: Amgicin 200 Gemcitabine Injection is used in the treatment of various cancers, including pancreatic cancer, breast cancer, ovarian cancer, and non-small cell lung cancer.

Q: When is Amgicin 200 contraindicated?

A: Amgicin 200 is contraindicated in patients with a known hypersensitivity to gemcitabine or any of its components. It should not be used in individuals with such allergies.

Q: Where should Amgicin 200 be stored to maintain efficacy?

A: This injection should be stored below 25C and protected from light to preserve its potency and ensure a full shelf life of up to 24 months.

Q: What are the key precautions and potential adverse effects to consider?

A: Use Amgicin 200 with caution in patients with renal or hepatic impairment. Possible adverse effects include myelosuppression, nausea, vomiting, rash, and fever.

Q: How does the packaging of Amgicin 200 ensure safety and quality?

A: Each sterile, single-use vial is packaged individually in a box, ensuring both safety and precise dosing for every patient in hospital and clinical settings.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Medicines Category

Abiracure Abiraterone Acetate 250mg Tablet

Abiracure Abiraterone Acetate 250mg Tablet

Minimum Order Quantity : 100 Boxes

Storage Instructions : Store at room temperature

Physical Color/Texture : Other , White to offwhite tablet

Dosage Form : Tablet

Indication : Prostate cancer

Salt Composition : Abiraterone Acetate 250mg

Emeset-4 ondansetron 4mg Tablet

Emeset-4 ondansetron 4mg Tablet

Minimum Order Quantity : 10 Pieces

Storage Instructions : Store in a cool, dry place, protected from light

Physical Color/Texture : Other , White to offwhite tablet

Dosage Form : Tablet

Indication : Prevention and treatment of nausea and vomiting

Salt Composition : Ondansetron 4mg

Ramiven Abemaciclib 100mg film coated Tablet

Ramiven Abemaciclib 100mg film coated Tablet

Minimum Order Quantity : 10 Pieces

Storage Instructions : Store below 30C, protect from moisture and light

Physical Color/Texture : Other , Filmcoated tablet (exact color not specified)

Dosage Form : Filmcoated Tablet

Indication : Used in the treatment of advanced or metastatic breast cancer

Salt Composition : Abemaciclib 100mg

Instgra Dolutegravir 50 Mg Tablets

Instgra Dolutegravir 50 Mg Tablets

Minimum Order Quantity : 10 Packs

Storage Instructions : Store below 30C, keep in original package to protect from moisture

Physical Color/Texture : Other , Tablet, standard pharmaceutical tablet form

Dosage Form : Tablet

Indication : Human Immunodeficiency Virus (HIV1) infection

Salt Composition : Dolutegravir 50 mg



Back to top